Rentschler Commissions New 2000-L Single-Use Bioreactor

Rentschler Biotechnologie has announced that its new 2000-L single-use bioreactor has been put into operation.

The new bioreactor, built and commissioned in only 6 months, doubles Rentschler’s single-use manufacturing capabilities. It seamlessly integrates in the existing manufacturing suites by supplementing two already existing 1000-L single-use bioreactors.

With this new bioreactor Rentschler joins the league of only a handful of companies having a 2000-L single-use bioreactor at their disposal, which is today’s maximum working volume in single-use.

“The new bioreactor is already very well booked months before its commissioning which proves the high level of confidence customers have in our company,” says Frank Ternes, Chief Business Officer at Rentschler. “With this new addition to our facility we strengthen our position in single-use biomanufacturing further and get closer to our goal to manufacture phase III clinical supplies and market supplies completely in single-use.”

Rentschler has more than 5 years’ experience with single-use bioreactors and features a facility with a completely flexible space concept and movable equipment. Single-use equipment reduces contamination risks and manufacturing costs. It permits a faster product turnaround and a shortened setup time and hence increases the capacity utilisation.

Rentschler is also experiencing a high demand for stainless steel manufacturing and will invest €24 million to build a Twin system with two 3000-L stainless steel bioreactors.